Product Program year 2020 Source: CMS Open Payments

BD Pharmingen

Device Cell Analysis

Open in the dashboard

General payments

$965,400

427 payments

Research payments

$0

0 payments

Through program year 2020, $965,400 in general payments and $0 in research payments were reported against BD Pharmingen (Cell Analysis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $410,124 217
2019 General $555,276 210

Breakdown

Who paid General payments · program years 2019–2020
  1. Becton, Dickinson and Company $965,400 427 payments
Top recipients General payments · program year 2020
  1. Dana-Farber Cancer Institute Teaching hospital · MA $112,054 27% · 29 payments
  2. Childrens Hospital Corporation Teaching hospital · MA $71,918 18% · 38 payments
  3. John Pesando Hematology & Oncology · Seattle, WA $62,332 15% · 14 payments
  4. University Of Washington Med Ctr Teaching hospital · WA $50,541 12% · 20 payments
  5. Brigham And Womens Hospital Teaching hospital · MA $48,460 12% · 40 payments

The top 5 of 15 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Hematology & Oncology Internal Medicine $62,332 97% · 1 practitioner
  2. Clinical & Laboratory Immunology Allergy & Immunology $2,244 3% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Massachusetts $245,311 60% · 6 recipients
  2. Washington $112,873 28% · 2 recipients
  3. Pennsylvania $34,616 8% · 1 recipient
  4. Texas $7,352 2% · 2 recipients
  5. Colorado $5,907 1% · 1 recipient

The top 5 of 8 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

427 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record